BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Up 188.0% in March

BlackRock Health Sciences Term Trust (NYSE:BMEZGet Free Report) was the target of a significant increase in short interest during the month of March. As of March 13th, there was short interest totaling 36,205 shares, an increase of 188.0% from the February 26th total of 12,573 shares. Based on an average daily volume of 225,332 shares, the short-interest ratio is currently 0.2 days.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Institutional investors and hedge funds have recently bought and sold shares of the company. CWM LLC raised its stake in shares of BlackRock Health Sciences Term Trust by 25.6% during the 4th quarter. CWM LLC now owns 3,336 shares of the company’s stock valued at $50,000 after purchasing an additional 680 shares during the period. Steward Partners Investment Advisory LLC boosted its stake in BlackRock Health Sciences Term Trust by 4.9% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 14,687 shares of the company’s stock worth $221,000 after purchasing an additional 688 shares during the period. Chapin Davis Inc. grew its holdings in BlackRock Health Sciences Term Trust by 3.2% during the 3rd quarter. Chapin Davis Inc. now owns 27,605 shares of the company’s stock valued at $398,000 after buying an additional 849 shares in the last quarter. Private Advisor Group LLC grew its holdings in BlackRock Health Sciences Term Trust by 3.5% during the 3rd quarter. Private Advisor Group LLC now owns 28,039 shares of the company’s stock valued at $404,000 after buying an additional 940 shares in the last quarter. Finally, Brown Lisle Cummings Inc. increased its position in shares of BlackRock Health Sciences Term Trust by 3.4% during the third quarter. Brown Lisle Cummings Inc. now owns 46,666 shares of the company’s stock valued at $673,000 after buying an additional 1,554 shares during the period.

BlackRock Health Sciences Term Trust Stock Performance

BMEZ stock traded down $0.27 during mid-day trading on Friday, hitting $13.77. The company had a trading volume of 352,989 shares, compared to its average volume of 285,474. BlackRock Health Sciences Term Trust has a 12 month low of $12.58 and a 12 month high of $15.80. The stock’s fifty day moving average price is $14.83 and its two-hundred day moving average price is $14.89.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, June 15th will be issued a $0.11 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 9.6%. The ex-dividend date of this dividend is Monday, June 15th.

About BlackRock Health Sciences Term Trust

(Get Free Report)

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.

Recommended Stories

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.